Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,090 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Osteogenic effects and safety of human induced pluripotent stem cell-derived megakaryocytes and platelets produced on a clinical scale.
Arai T, Shiga Y, Mukai M, Takayama N, Tashiro S, Tajiri I, Kosaka K, Sato M, Nakamura S, Okamoto H, Kimura S, Inage K, Suzuki-Narita M, Eguchi Y, Orita S, Eto K, Ohtori S. Arai T, et al. Among authors: kosaka k. Regen Ther. 2024 Oct 3;26:850-858. doi: 10.1016/j.reth.2024.09.012. eCollection 2024 Jun. Regen Ther. 2024. PMID: 39430581 Free PMC article.
iPSC-derived megakaryocytes and platelets accelerate wound healing and angiogenesis.
Kosaka K, Takayama N, Paul SK, Kanashiro MA, Oshima M, Fukuyo M, Rahmutulla B, Tajiri I, Mukai M, Kubota Y, Akita S, Furuyama N, Kaneda A, Iwama A, Eto K, Mitsukawa N. Kosaka K, et al. Stem Cell Res Ther. 2024 Oct 14;15(1):364. doi: 10.1186/s13287-024-03966-z. Stem Cell Res Ther. 2024. PMID: 39402677 Free PMC article.
Exposure to volatile ferroptosis inhibitor, TEMPO, reduced cutaneous ischemia-reperfusion injury progression to pressure ulcer formation in a mouse model.
Ishikawa M, Uchiyama A, Kosaka K, Nishio M, Ogino S, Yokoyama Y, Torii R, Akai R, Iwawaki T, Torii S, Motegi SI. Ishikawa M, et al. Among authors: kosaka k. J Dermatol Sci. 2024 Sep;115(3):130-140. doi: 10.1016/j.jdermsci.2024.07.005. Epub 2024 Jul 27. J Dermatol Sci. 2024. PMID: 39098373 Free article.
Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial.
Otsuki T, Akada S, Anami A, Kosaka K, Munjal I, Baber J, Shoji Y, Aizawa M, Swanson KA, Gurtman A. Otsuki T, et al. Among authors: kosaka k. Vaccine. 2024 Sep 17;42(22):126041. doi: 10.1016/j.vaccine.2024.06.009. Epub 2024 Jun 8. Vaccine. 2024. PMID: 38853036 Free article. Clinical Trial.
1,090 results